InVitria, Inc. Employee Directory
Biotechnology ResearchKansas, United States11-50 Employees
InVitria, Inc. operates in biotechnology research, developing recombinant proteins that are defined, scalable, and animal-origin-free, with the aim of improving manufacturing and formulation for biologics. Its offerings span applications across cell and gene therapies, vaccines, biopharmaceuticals, CAR T cell therapy, stem cells, medical devices, and regenerative medicines. The company emphasizes chemically defined components to support manufacturing efficiency and formulation stability in these areas. Headquartered in Junction City, Kansas, the company operates as a small to mid-sized biotechnology firm. In March 2026, InVitria announced a strategic collaboration with Cellevate AB to integrate its media with Cellevate's Cellevat3d nanofiber microcarrier platform, aiming to advance upstream bioprocessing solutions. This partnership signals a focus on expanding bioprocessing capabilities through collaboration with other biopharma technology providers.